Company intelligence / Profile preview

Biomarker Services

Raleigh, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Biomarker Services was a specialized contract research organization (CRO) that provided laboratory services focused on the discovery, development, and validation of biomarkers for oncology clinical trials. The company supported pharmaceutical and biotechnology partners by offering assay development, clinical sample analysis, and regulatory support to streamline drug development programs. In 2014, the company was acquired by Cancer Genetics, Inc. to enhance their clinical trial services and expand their footprint in the oncology biomarker space. Following the acquisition, its operations were integrated into the parent company's clinical services division.

Therapeutic areas: Oncology
Industry: Contract Research Organization

Partnerships

Cancer Genetics

Beyond the preview

Go deeper on Biomarker Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomarker Services.

Explore the full profile